WHO expands mpox emergency testing centres

The World Health Organisation (WHO) has listed two additional mpox in vitro diagnostics under its Emergency Use Listing (EUL) procedure to enhance quality-assured testing options.
The organisation stated this in a statement on Wednesday.
The organisation stated that “WHO’s EUL is based on the review of quality, safety and performance data in compliance with international standards, while addressing specific needs of Low- and Middle-Income Countries (LMICs).
“Polymerase Chain Reaction (PCR) testing, which detects viral DNA, is considered the gold standard for diagnosing mpox infection.”
The organisation identified the Xpert Mpox, a real-time PCR test manufactured by Cepheid under EUL procedure on Oct. 25 as test designed for use on compatible GeneXpert systems.
“The Xpert Mpox test is easy to operate and delivers results in 40 minutes. Once the cartridge is placed in the system, the process is fully automated, with real-time PCR detecting viral DNA of monkeypox virus clade II.
“The GeneXpert system is a near-point-of-care testing option which can support decentralised testing.”
The global health body added that another PCR-based option, the cobas MPXV assay, developed by Roche Molecular Systems, Inc., was listed on Oct. 14.
According to the statement, this was intended for use on the cobas 6800/8800 systems.
“This tool is a real-time PCR test capable of detecting both mpox clades and delivering results in two hours.
“It can process multiple samples simultaneously and suitable for clinical laboratories that handle large volumes of tests,” it said.
It stressed that ensuring global access to mpox diagnostic test is essential for efficient and effective testing in settings affected by mpox outbreaks.
“Rapid access to those listed products is critical not only for prompt diagnosis and timely treatment but also for effectively containing of the spread of the virus”, it said.
It stressed that ensuring global access to mpox diagnostic test is essential for efficient and effective testing in settings affected by mpox outbreaks.
“Rapid access to those listed products is critical not only for prompt diagnosis and timely treatment but also for effectively containing of the spread of the virus”, it said.
Dr Rogerio Gaspar, WHO director for regulation and prequalification said WHO previously listed Alinity m MPXV assay, manufactured by Abbott Molecular Inc. under EUL on Oct. 3.
He said that in 2024, 18 countries reported more than 40,000 suspected mpox cases, with most remaining unconfirmed due to limited testing capacity, especially in LMICs.
According to him, in the Democratic Republic of the Congo, the hardest-hit country, testing has significantly increased in 2024, following efforts to decentralise testing with support from WHO and partners.
“However, the proportion of tested cases remain low, accounting for 40-50 per cent of suspected cases.
“WHO is working with manufacturers of the EUL-listed products and national regulatory authorities in affected countries to facilitate domestic registration or emergency listing.
“Fast-tracking approvals and applying reliance principles will enhance access to quality-assured mpox tests,” Gaspar said.
He said that overall, WHO received more than 60 expressions of interest for the EUL review of mpox diagnostic tests.
“However, seven of these progressed to EUL applications, with two products currently under review and two more expected soon.
“The status of active applications and listed mpox diagnostics under WHO EUL procedure can be seen on WHO webpages,” he said.
(NAN)
We have recently deactivated our website's comment provider in favour of other channels of distribution and commentary. We encourage you to join the conversation on our stories via our Facebook, Twitter and other social media pages.
More from Peoples Gazette

States
Independence: NBA urges Nigerians to expect better future
The NBA said that ordinary Nigerians should be deriving benefit from the subsidy removal rather than hardship.

Agriculture
FG tasks ECOWAS on leveraging financing strategies for agroecology
The federal government has urged stakeholders in the agriculture and finance sectors in the West Africa region to leverage financing strategies to enhance agroecology practices

Politics
Katsina youths pledge to deliver over 2 million votes to Atiku
“Katsina State is Atiku’s political base because it is his second home.”

World
NVIDIA board rejects Huang’s possible return as CEO
NVIDIA chairman Harvey Jones said the board unanimously accepted Mr Huang’s resignation and had no plans to reinstate him.

Anti-Corruption
Court fixes December 2 to arraign NEDC coordinator over alleged N2.2 billion fraud
The EFCC alleged that the defendants obtained N2.2 billion from the company through false pretences.

Abuja
Wike urges Abuja traders to back Tinubu’s 2027 re-election bid
Mr Wike acknowledged the hardship caused by the fuel subsidy removal but said previous administrations failed to address the problem because they lacked the courage.

States
Ibom Air records N5.49 billion profit, seeks fresh investment from Akwa Ibom govt
Ibom Air recorded revenue of N147.03 billion, representing a 52 per cent increase from the N96.53 billion earned in 2024.

World
Gulf nations scramble to intercept fire after U.S. strike on Qeshm Island
Explosions were heard in Saudi Arabia, the world’s biggest crude oil exporter, which said it intercepted a cruise missile fired by the Iran-backed Houthis

Economy
Seplat chairman Udo Udoma buys $370,000 company bonds for $397,077
The amount paid was $27,076.81above the securities’ face value, representing a premium of approximately 7.3 per cent.





